首页    期刊浏览 2024年12月02日 星期一
登录注册

文章基本信息

  • 标题:In silico study for evaluating the binding mode and interaction of 1, 2, 4-triazole and its derivatives as potent inhibitors against Lipoate protein B (LipB)
  • 本地全文:下载
  • 作者:Shola Elijah Adeniji ; Sani Uba ; Adamu Uzairu
  • 期刊名称:Journal of King Saud University - Science
  • 印刷版ISSN:1018-3647
  • 出版年度:2020
  • 卷号:32
  • 期号:1
  • 页码:475-485
  • DOI:10.1016/j.jksus.2018.07.014
  • 语种:English
  • 出版社:Elsevier
  • 摘要:AbstractTuberculosis (TB) is an infectious disease caused by bacterium specie known asMycobacterium tuberculosis.Emergence of multi-drug resistant strains ofM. tuberculosisled to the development of new and more potent anti-tuberculosis agents. A novel series of 1, 2, 4-triazole derivatives have been reported as better anti-tubercular agents. Thus, Lipoate biosynthesis protein B (LipB) was selected as a potential drug target and docked with the inhibitors to evaluate the binding mode and interaction. The Molecular docking analysis showed that nearly all the compounds bind strongly to active sites of the target with binding affinities ranging from (−4.1 to −17.9 kcal/mol) which correlates with their activities. Ligands (compound 16 and 34) have the best binding affinity of (−15.8 and −17.9 kcal/mol) which formed hydrophobic interaction and hydrogen bond with amino acid residues ofM. tuberculosisLipoate protein B (LipB). This research has shown that the binding affinity of these compounds were found to be better than the recommended anti-mycobacterium drugs; isoniazid (−14.6 kcal/mol) and ethambutol (−5.8 kcal/mol). This study provides a valuable approach for designing and synthesizing more potent anti-mycobacterium tuberculosis derivatives.
  • 关键词:Binding affinity;1, 2, 4-triazole;Molecular docking;M. tuberculosis;LipB
国家哲学社会科学文献中心版权所有